John A. Zuris
0009-0009-3363-7597
Publication & Citation Trends
Most Cited Works
Publications
40 total
A highly efficient transgene knock-in technology in clinically relevant cell types
Cited by 58
OpenAlex
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo OA
Cited by 36
Semantic Scholar
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines PDF
Cited by 169
OpenAlex
A Bicistronic Vector Expressing CD16 and a Membrane Bound IL-15 Construct in iPSC Derived NK Cells Increased Cytotoxicity and Persistence OA
Cited by 3
Semantic Scholar
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines OA
Cited by 4
Semantic Scholar
191 GAPDH knock-in of high affinity CD16 in iPSC derived NK cells drives high-level expression and increased anti-tumor function OA
Cited by 0
Semantic Scholar
Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T Cells
Cited by 58
OpenAlex
EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD OA
Cited by 28
Semantic Scholar
Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation Model
Cited by 6
Semantic Scholar
Research Topics
CRISPR and Genetic Engineering
(14)
Metalloenzymes and iron-sulfur proteins
(14)
CAR-T cell therapy research
(6)
Metal-Catalyzed Oxygenation Mechanisms
(6)
RNA regulation and disease
(5)
Frequent Co-Authors
Affiliations
Broad Institute
Howard Hughes Medical Institute
Harvard University
Hebrew University of Jerusalem
University of California, San Diego